Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2018, with the United States Securities and Exchange Commission, (the “SEC”) on Tuesday May 15, 2018.

Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to report our first quarter of 2018 results with increases of approximately 7% and 14%, for net revenue and gross profit, respectively, compared to the same period one year ago. With the successful completion of our acquisition of CPM Medical Consultants, LLC, reflected positively in our 2017 Annual Report on Form 10-K filing, all of us at Fuse are very excited about what this partnership will mean for our next phase of growth, as well as the benefits it offers our customers. We are pleased with our progress and will continue to execute our strategic objectives.”

The filing can be found on the Company’s website at https://fusemedical.com/investors.

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment